Retrobulbar chlorpromazine injections for the management of blind and seeing painful eyes.
| Autor: | Chen TC; Glaucoma Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02114, USA. teresa_chen@meei.harvard.edu, Ahn Yuen SJ, Sangalang MA, Fernando RE, Leuenberger EU |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of glaucoma [J Glaucoma] 2002 Jun; Vol. 11 (3), pp. 209-13. |
| DOI: | 10.1097/00061198-200206000-00008 |
| Abstrakt: | Purpose: To report the efficacy of primary retrobulbar chlorpromazine injections for the management of blind and seeing painful eyes. Patients and Methods: Retrospective case series from three university hospitals was done. Twenty eyes of 20 patients with at least 3 months of follow-up are reported. Ten of these 20 eyes did not receive any other ophthalmic medications either 2 weeks before chlorpromazine injection or at any time point after injection. Treatment was considered successful if pain control lasted for at least 3 months, without the need for reinjection or enucleation. Results: Sixteen of 20 (80.0%) eyes achieved successful pain control. There were no permanent complications in any patient. Conclusions: Retrobulbar chlorpromazine appears to be safe and effective for the management of pain in blind eyes. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|